NAV per share reduced by 57.5%
Analysts question lack of visibility
Draws comparison to Hipgnosis
Several investment adviser shortcomings
No intention to recommence dividends
Follows valuation health warning
Manager’s termination option rights
'More of a challenge than Brexit'